| Symbol | SPHRY |
|---|---|
| Name | STARPHARMA HOLDINGS LTD. |
| Sector | UNDEFINED |
| Region | Oceania |
| Industry | - |
| Address | 3067 Australia VA 4-6 Southampton Crescent |
| Telephone | +61 3 8532 2700 |
| Fax | — |
| — | |
| Website | http://www.starpharma.com |
| Incorporation | AU |
| Incorporated On | 1997 |
| Employees | — |
| Fiscal Year | 6/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | PricewaterhouseCoopers LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: ASX - Australian Securities Exchange |
| CIK | 0001308380 |
| Description | Starpharma Holdings Limited (ASX: SPL, US OTC: SPHRY) is an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient. Our mission is to help patients with significant illnesses, such as cancer, achieve improved health outcomes and quality of life through the application of our unique dendrimer technology. Additional info from OTC: |
No news found.